Beranda › Sklerosis Multipel › Texas › Dallas
Uji klinis Sklerosis Multipel di Dallas, TX
6 studi untuk Sklerosis Multipel mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Menerima pesertaStudi observasional
- TG Therapeutics Investigational Trial Site, Dallas
- TG Therapeutics Investigational Trial Site, Dallas
Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Menerima pesertaFase 3
- UT Southwestern Medical Center (Ophthalmology CRU), Dallas
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Menerima pesertaFase 3
- Carum Research, Dallas
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
Menerima pesertaFase 2
- University of Texas Southwestern Medical Center, Dallas
NARCOMS Registry: A Multiple Sclerosis Registry
Menerima pesertaStudi observasional
- UT Southwestern Medical Center, Dallas
Uji klinis Sklerosis Multipel di kota lain
- New York City, NY17 studi
- Chicago, IL15 studi
- Boston, MA14 studi
- Washington, DC13 studi
- Cleveland, OH9 studi
- St. Louis, MO8 studi
- Kansas City, KS8 studi
- Birmingham, AL8 studi
- San Francisco, CA8 studi
- Columbus, OH7 studi
- Aurora, CO7 studi
- Baltimore, MD7 studi
Studi lain di Dallas
- Kanker Payudara55 studi
- Kanker Paru Non-Sel Kecil52 studi
- Kanker Metastatik42 studi
- Gagal Jantung42 studi
- Kanker (semua jenis)37 studi
- Kanker Prostat36 studi
- Kanker Kolorektal33 studi
- Obesitas30 studi
- Kanker Ovarium28 studi
- Kanker Kandung Kemih27 studi
- Kanker Paru27 studi
- Kanker Endometrium24 studi
Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.